This action might not be possible to undo. Are you sure you want to continue?
Dr. RAMAKRISHNA SISTLA firstname.lastname@example.org email@example.com Phone: 040-27173345 (Res.) 040-27193004 (Off.) Fax: 040-27193753
Scientist E1 Pharmacology Division Indian Institute of Chemical Technology (IICT) Hyderabad-500 007, A.P. India
Academic qualifications: * 1999 Ph.D. (Technology), Pharmacology Division, Indian Institute of Chemical Technology, Hyderabad, A.P., India. Awarded by Faculty of Technology, Osmania University, Hyderabad, India. M. Pharmacy (Pharmaceutical Technology), Andhra University, Visakhapatnam, A.P., India First Division (with Distinction) B. Pharmacy, Andhra University, Visakhapatnam, A.P., India First Division.
Awards and Fellowships:
Awarded Associate Fellow of A. P. Academy of Sciences, Hyderabad. Awarded Graduate Aptitude Test in Engineering (GATE) by University Grants Commission (UGC), New Delhi during M. Pharm. Awarded Senior Research Fellowship (SRF) from Council of Scientific and Industrial Research (CSIR), New Delhi to pursue Ph.D. program.
Areas of Interest: Pharmacological Screening, Pharmacokinetics, Novel Drug Delivery Systems and Regulatory Toxicology. Current Affiliation: * 2001 – Working as Scientist in Pharmacology Division, Indian Institute of Chemical Technology (CSIR), Hyderabad, India.
Sistla Ramakrishna. Hyderabad. and M. No: 3. Indian Institute of Chemical Technology. Steve Thomas. P..53(3):1387-91. 822-831. 2. J Enzyme Inhib Med Chem. T. Majeti BK. 4. 2010 Feb 11. 2009. India. Ramakrishna S. Chaudhuri A. Journal of Natural Remedies.25(1):806. . Experience: * 1999-2001 Worked as Research Associate in Pharmacology Division. G. Madhusudhana K. IICT to pursue Ph. Karmali PP. alpha-glucosidase inhibitory. Projects related to pharmacokinetic evaluation of NCEs. Reddy BS. 3.V. India * 1998-1999 Worked as lecturer in Sri Venkateshwara College of Pharmacy. Rajaji Nagar. 2009. Ramakrishna. Srinivas G. Subjects taught: Pharmaceutics. Nalini Shastri. Sponsored projects related to regulatory toxicity. Srilakshmi. Bio-pharmaceutics and Pharmacokinetics. Vol 1. 202-208 2. J Med Chem. S. Worked in the area of formulation and pharmacokinetic evaluation of compressed suppositories of NSAIDs suitable to tropical climates. Surface Solid Dispersion of glimepiride for enhancement of dissolution rate. Projects related to pharmacological evaluation 3. Ganapathy. Raja Rajeswari and S. Vol: 9/2. Venkata Mahidhar Y. Bangalore in the manufacturing of tablets. Kumar JA. Kiran. Garu A. program.K. Tiwari AK. Ramakrishna S. Cytotoxicity and antiprotozoal activity of flavonoids from three Tephrosia species. Cationic amphiphile with shikimic Acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization. Madhapur. capsules and liquid oral departments.Categories of Projects (in house and sponsored) handling currently: 1.. China Raju B. Srinivas R. * 1990-92 Research papers published: 1. 2010 Feb. and cytotoxic derivatives of benzimidazoles. Worked in M/s Anglo-French Drug Company.D. * 1993–98 Worked as Senior Research Fellow of CSIR in Pharmacology Division. N. Pramanik D. International Journal of Pharm Tech Research. Ali AZ. Sadanandam. Hyderabad. New antihyperglycemic.
Khar. Vinay Kumar Venishetty.Apparao Thoomu. (IF: 1. Synthesis and biological evaluation of novel tetracyclic benzothiazepines. Polyelectrolyte complexes of gum kondagogu and chitosan. 2008 Nov 27. Madhavi. Invitro evaluation of surface modified solid lipid nanoparticles for oral delivery of carvedilol. VenishettyVinay Kumar and Sistla Ramakrishna. and Arabinda Chaudhuri.782) 11. Biomaterials. Sanjoy Samanta Ramakrishna Sistla and Arabinda Chaudhuri. 8. Karmali PP.51(22):7298-302. Vegi GangaModi Naidu. Radha D. Mahidhar Y. Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver. Vinay Kumar Venishetty. Phosphorus. Agawane.M. Chaudhuri A. Ritonavir and Lopinavir in Solid Lipid Nanoparticles by RP-LC. Nirali Parikh. Reddy. Madhusudhana. Journal of Chromatographic Sciences (In Press). 2009. and Silicon. Ramakrishna Sistla and Prakash Diwan. Mondal G. Putchaa Udaykumar.(IF: 6. Biomaterials. K. Venkata. 2009 (In press). (IF: 3. 2369-2384. 30. Single Subcutaneous Administration of RGDK-Lipopeptide:rhPDGF-B Gene Complex Heals Wounds in Streptozotocin-Induced Diabetic Rats. Article ASAP. Diwan. Srinivasa R. 9. Praveen K. 13. Pramanik D.262). Rupavani G and Ramakrishna Sistla. Pande G. Majeti BK. 10. and the Related Elements (In Press) 7. Sashidhar. Current Nanoscience (In Press). R. Carbohydrate Polymers 76 (2009) 464– 471. Roop K Khard and Prakash V Diwan. Vegi. as diclofenac carriers.5) . Venkat R. Gangireddy. Chromatographia (In Press) 6. The use of RGDGWK-lipopeptide to selectively deliver genes to mouse tumor vasculature and its complexation with p53 to inhibit tumor growth. Ramakrishna.G. Lipopeptide with a RGDK tetrapeptide sequence can selectively target genes to proangiogenic alpha5beta1 integrin receptor and mouse tumor vasculature. Application of validated reverse phase HPLC method for simultaneous determination of doecetaxel and ketoconozole in solid lipid nanoparticles. Kuncha Madhusudana. Sashidhar Rao Beedu.5. Farhan J. Venkateshwaralu Peesapati. Ramakrishna Sistla and Arabinda Chaudhuri. Sulfur. Molecular Pharmaceutics.B. a natural biopolymer. J Med Chem.. Emulsifying properties of gum kondagogu (Cochlospermum gossypium).Konda. Srujan Marepally. Gangamodi N. Sistla Ramakrishna.3) 12. Ramakrishna Sistla. Rajesh Mukthavaram. Roop K. Ramakrishna Sistla. Palaniappan Srinivasan. Goutam Mondal. Srinivas G. Simultaneous Determination of Ketoconazole. Farhan J. Parikh Nirali. Siripuram Parthasaradi Ramakrishna Rao. Sachin B. Ahmed and Prakash Vamanrao Diwan. 14. J Sci Food Agric 2009 (In press) (IF: 1. S. Jayanta Bhattacharyya. V. Ahmed and Prakash V. Sistla R. Naidu. Ramprasad OG..
1 . (IF: 2. Biomaterials.1-c][1. Sreedhar. Podaralla Satheesh Kumar. 18. Ramakrishna Sistla and Arabinda Chaudhuri. Issue 7.-glucuronide prodrugs with a Potential for selective therapy of solid tumors by PMT and ADEPT strategies. Sachin B. Drug Delivery. Sistla Ramakrishna and Prakash V.G. Rentam Kiran Kumar Reddy. Issue 14. Madhusudana Rao. Evaluation of Antioxidant and antimicrobial properties of Soymida Febrifuga leaf extracts. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. (IF:2. Agwane. Robinson. J.*. Tulsi Ram Saini.604). 19. M. Volume 18. 14. Boreddy Srinivas Reddy. Naidu. Sistla Ramakrishna and Prakash V. Suresh Babu.a P. R.a V. Pyrrolo[2.604). A. Pages 3769-3773.640). K. Madhusudhana. G. The development of folate. Joyeeta Sen.430). Vol 28. (IF: 4. Srinivas. Khar and Prakash V.15. Durairaj Chandrasekar. Evaluation of antimicrobial. K. Bioorganic & Medicinal Chemistry Letters. V. Sistla Ramakrishna . P. Farhan J Ahmad. Diwan. J. Pages 4015-4017. Naidu. Issue 13. Vijay Kumar. Diwan. Date: July 2008. 20. Pages 3429-3442. T.PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. 23.186). 517-523.Chem. Vol 51(6). b Ramakrishna Sistlab . Sapireddy Veer Raghavulu. Diwan.G. Kiran Kumar Reddy. Venkata Kashyap Yellepeddi. 2007. Boreddy Purushottam Reddy. V. 2007. Naidu.M. Rooop K. 2008. Bioorganic & Medicinal Chemistry Letters. Phytotherapy Research Volume 22.049). E. 2008. Ramakrishna Sistla.262). Ventakeswarlu and Prakash V Diwan. antioxidant and wound healing potentials of Holoptelea integrifolia .(IF:2. Diwan. 1 July 2008. (IF: 1. Journal of Ethnopharmacology. 16. Boreddy Srinivas Reddy. Diwan. 21.M.V. Novel Approach for Delivery of Insulin Loaded Poly(lactide-co-glycolide) Nanoparticles Using a Combination of Stabilizers. a Venkatesh Tekumalla. Durairaj Chandrasekar. Koushik Mukherjee Jayanta Bhattacharyya. 19671971. 15 July 2008. Sistla Ramakrishna and Prakash V. (IF: 1. Boreddy Purushotham Reddy. 22.895). Boreddy Srinivasa Reddy.Med. Durairaj Chandrasekar. November 2008. A new sesquiterpene lactone from the roots of Sassurea lappa: Structure-Anticancer activity study. Food and Chemical Toxicology. Volume 46. (IF: 6.b Prakash V. Volume 18. 115( 2). 17. Ahmed Kamal. (IF: 2. Pages: 943-947. Issue 11. 504-512.4]benzodiazepine. Potential in vitro antioxidant and protective effects of Soymida febrifuga on ethanol induced oxidative damage in HepG2 cells. Sistla Rama Krishna. Raju. 249-256. Covalent Grafting of Common Trihydroxymethylaminomethane in the Headgroup Region Imparts High Serum Compatibility and Mouse Lung Transfection Property to Cationic Amphiphile. Y.
Ramakrishna Sistla. Development and validation of a reversed-phase HPLC method for the determination of nitrendipine in rat plasma: application to pharmacokinetic studies. 30. Samala Malla Reddy. 167-175. Sistla Ramakrishna. 2006. Helvetica Chimica Acta . 2007. Issue 33. Tulsi Ram Saini and Prakash V Diwan. Laatsch and Y. Venkateswarlu.Ramakrishna Sistla. 25. Sistla VSSK Tata.515). 363-368. Sarin R. Saiprakash and Sistla Ramakrishna. 28. (IF: 2.K. Journal of Biomedical Materials Research.612). 31.(IF: 2. 21(4).1 Farhan J. 29(7). Veluri Ravikanth. P.2 Prakash V. 61(7). Krishnaiah. (IF: 1. 24. Yamsani Madhusudan Rao and Prakash Vamanrao Diwan. Published online 31 Jan 2007 (Article online in advance of Print).068). International Journal of Pharmaceutics. 15 August 2005. Durairaj Chandrasekar. Madhusudhana. Khar. 2007. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. S. Influence of microencapsulation method and peptide loading on formulation of poly (lactide-co-glycolide) insulin nanoparticles. Vanimireddy Lakshmi Niranjan Reddy. Ramakrishna and Prakash V. . P. Vijender Reddy.615).760). Ravinder. P. Sistla Ramakrishna. Diwan. pp 2527-2531. R. K. S. Chandrasekar Durairaj. 613-617. 26. Issue 2. Pages 460-464. Simple liquid chromatographic method for the rapid and simultaneous determination of propoxur and its major metabolite isopropoxy phenol in rat blood and urine using solid phase extraction. Determination of DPPH free radical scavenging activity by reversed-phase HPLC: A sensitive screening method for polyherbal formulations. 29. Vinay Kumar Venishetty. Journal of Pharmaceutical and Biomedical Analysis. 2005. 728-733. Vol 335. Development and validation of Reversed Phase HPLC method for the determination of ezetimibe in Pharmaceutical Dosage forms. Lewis Acid Catalyzed. Yenamandra Venkateswarlu . Venishetty Vinay Kumar. Die Pharmazie. Pages 5475-5478. Journal of Analytical Toxicology SOFT 2005 Special Issue. 13 February 2006. Ahmad.K. Volume 40. 27. A.). Masuna Srinivasulu. H. Madhusudhan Rao Yamsani and Prakash V Diwan. D. (IF: 1. (IF: 2. Biomedical Chromatography. Ramesh. Ramakrishna. Isolation and synthesis of a novel β-carboline guanidine derivative tiruchanduramine from the Indian ascidian Synoicum macroglossum K. Veerabrahma Kishan. Diwan. Ramagiri Suma.663). 2005.408). Selective Cyclopropane-Ring Opening in Ingol Diterpene Derivatives. Vol.2 Roop K. Volume 88(9). Tuniki Venugopal Raju. YV Kasyap. (IF: 2. D.Sistla Ramakrishna. (IF: 2. Tetrahedron Letters. Podaralla Sateesh Kumar. Chandrasekar. Volume 46.
(IF: 3.3). Niranjan Reddy. 2004. S. V. AAPS Pharm. Diwan. (IF: 5. S. Venkateswarlu. 81-85. (IF: 2. 40. 33. 6(1). Ramakrishna and Prakash V diwan. 2004. Drug release kinetics from polymeric films containing propranolol hydrochloride for transdermal use.P.551). New lamellarin alkaloids from the Indian Ascidian Didemnum obscurum and their anti oxidant properties. K. 67. 331-335. Sistla Ramakrishna. V.S. P. Surender Reddy. K. 2003.L. T.R. M. USA. Ramakrishna and Prakash V. pp 655-659. 260-263.Chandrasekar and PV Diwan. 465-472. P.611). Ramakrishna Sistla and Prakash V. Article 7. Rama Rao. S. (IF: 2. (IF: 0. Pages 517-522. D. M. Sudheer Kumar Yadav. Ramakrishna.org. Bharat Kumar Majeti.V. 36. Srinivasulu. Diwan. European Journal of Pharmaceutics and Biopharmaceutics. (Germany). Ramakrishna and Y.756). D Chandrasekhar and Y. 38. Volume 39. 2004. 5(4). Rama Rao. Sujatha. Krishnaiah. Diwan. 92-97. (IF: 2. Chemistry and Biology. S. Narender Reddy. Ramakrishna and Prakash V. Indian Journal of Pharmaceutical Sciences. G Venkataramana. (IF: 2. Journal of Pharmaceutical and Biomedical Analysis. 2003. Comparative in-vivo evaluation of Propanolol Hydrochloride after oral and Transdermal administration in rabbits. M. M. Prabhakar Rao.V. 11. Ravikanth. VLN Reddy. 54(10). B.76). A rapid. 1168-1171. Rajkumar Sunil Singh. Sci (USA). characterization and dissolution studies. S. Chandrasekhar.718). Sistla Ramakrishna. Ravinder. P. 427-437.N. 32. -Cyclodextrin complexes of celecoxib: molecular modeling. Raju. Prakash V Diwan. Narender Reddy. P. Macrocyclic diterpenes from Euphoria nivulia. S. Ravikumar. Diwan. T. S. Enhanced Intravenous Transgene expression in Mouse Lung using Cyclic-head cationic lipids. 59. 39.692). 65(3). Ramakrishna. XLII (2. 56. Formulation and pharmacokinetic evaluation of compressed slow release suppositories of diclofenac sodium in rabbits. Tasneem Rehana. Pharmacy Development and Technology.322). and Prakash V. sensitive and validated method for the determination of ondensetron in human plasma. Acta Pharmaceutica Tursica (Turkey). Diwan. 34. Venkateswarlu. Reddy. Journal of Natural Products. . P. http://www. A simple and sensitive reverse phase HPLC method for the determination of Celecoxib in Rat Plasma. Abhay Singh Chauhan. Phytochemistry.876). 15 September 2005. 2002. 37. Madhavendra and Arabinda Chaudhuri. 2000. Diwan. (IF: 0. Arzneimittel Forschung/Drug Research. Issues 3-4. 2000. K. Chowdhary and Prakash V. 35.aapspharmsci.
P. (India) 28. 269-271.M/s Incogen Therapeutics Ltd. . Hyderabad – 2009. 2.2008 6. Improvement of dissolution efficiency of Ketoprofen by solvent deposition technique... 115-117.P. and Ramakrishna Sistla. Sponsored projects handled: 1. Chowdhary and S. Ind. 44.R. Prakash V. 1990. The Eastern Pharmacist. 1999. and Prakash V. Inflammopharmacology. Hyderabad . 1996. Diwan. 389. Comparative pharmacokinetic evaluation of compressed suppositories of Diclofenac sodium in humans.692). The Eastern Pharmacist. XXXIX (462). No. (IF: 0.R. Pharmacol. Bioavailability of Diclofenac sodium . Pharmacodynamic evaluation of a new parenteral formulation of omeprazole in rats.2008 . 3: 271-277. and Prakash V. 438. Pharmacokinetic studies in rodents for NCE's . 1996. The Eastern Pharmacist (India). (U.P. Diwan. Diwan. Arzneimittel Forschung/Drug Research. Pharm. Toxicity evaluation of new formulation of Docetaxel in rats and mice – Sponsored by M/s Therdose Pharma Ltd. Influence of Gymnema sylvestre on inflammation. K. 1994. Hyderabad . XXXVII.Comparison of rectal suppositories with oral suspension in rabbits. 46. 45. 275-281. (India) 52(6). Diwan.2009 4. 1996. 48. Sistla Ramakrishna. Hyderabad. (India) 61(5). Hyderabad . In vivo and in vitro evaluation of solvent deposited systems of indomethacin and naproxen. Rama Rao P. No. XXXIII. Chowdhary and S. Fadnavis and Prakash V. Malladi S. Ind. Ramakrishna.2008 5. 43. Margaret I. Ramakrishna. Nitin W.M/s Therdose Pharma. 47. Indian Journal of Pharmaceutical Sciences. K. 185-187. Hyderabad.41. To determine MTD of soluble polymers for intravenous/oral use . (Germany) 46(I). 175-177. 119-121. J. Diwan. 149-151. Ramakrishna Sistla and Prakash V. Ramakrishna Sistla. Ramakrishna S. J. Formulation and evaluation of compressed suppositories of indomethacin.M/s Incogen Therapeutics Ltd. Srinivas V. Ramakrishna Sistla. Toxicity evaluation of the herbal products – Sponsored by M/s Nandan Biomatrix Ltd. Toxicity evaluation of new formulation of Fulvestrant in rats – Sponsored by M/s Therdose Parma Ltd.(India) Vol. . Sastry and Prakash V. 1990. (India) Vol. Evaluation of water soluble cellulose polymers as carriers for ketoprofen solid dispersions. Diwan. 42. Pharmacodynamic studies in rodents for NCEs in the area of inflammation . Sci.K) 1995.2009 3.
January 2006 18. Hyderabad . New Delhi – May 2006 15. Hyderabad – April 2004 .. Acute and Sub-acute Toxicity Study of Ropivacaine Hydrochloride Injection (Formulation) in rats and mice. DRDE. CCRAS. Sponsored by M/s Confluent Surgicals. M/s Aurobindo Pharma Limited. CCRAS. April 2006 17. Influence of Ayush Manas on Episodic Memory in rats. 23. Dose Escalation and Tissue Distribution studies of Monoisoamyl Dimercaptosucinic Acid after oral Administration in rats. New Delhi – September 2006 13. Hyderabad.2007 8. Acute oral toxicity study of SMSRC –0401. Hyderabad-January 2006 21. New Delhi – April 2006 16. Gentox Bio Services Pvt Ltd.June 2005 22. Sudarshan Biotech. Acute toxicity study of Fosphenytoin Sodium (Formulation) administered intravenously in rats and mice. Hyderbad – February 2005. Hyderabad – September 2006 11. Gland Pharma.7. Acute oral toxicity of Citlopram Hydrobromide in rats and mice. Issar Pharmaceuticals Pvt Ltd. CCRAS. CCRAS. Evaluation of the In vivo efficacy of Peg-GCSF and GCSF by Cyclophosphamide (CPA) induced Neutropenia in mice.Gwalior. Evaluation of Immunomodulatory activity of Ayush formulations. New Delhi.August -2006 14. Acute Oral Toxicity Study of Proprietary Ayurvedic Medicine in Mice and rats. Nandan Biomatrix Limited. Sub acute and chronic toxicity study of Ayurvedic Bhasma “E” & “F” in rats and mice – Sponsored by CCRAS. IICT. M/s SMS Pharmaceuticals Ltd. Acute and sub acute toxicity study of Fosphenytoin sodium Injection (Formulation) in rats and mice. . 24. Hyderabad . Sub acute toxicity study of wound healing peptide (GENOPEP) in rats and rabbits. Hyderabad – November 2006 9. Hyderabad-January 2006 20. Sub acute toxicity study of Ayurvedic Bhasma’e’ in rats and mice. To Evaluate The Aphrodisiac Activity Of Safed Musli (Chlorophytum Borivilianum) In Adult Wistar Rats. New DelhiSeptember 2006 12. Hyderabad – March 2005. USA . GP Institute. Gland Pharma Limited. Hyderabad. Anti-Inflammatory Activity Of Divi’s Compounds By Carragennan Induced Rat Paw Edema Model M/s Divi’s Laboratories Limited. Gland Pharma Chemicals. Study of controlled release pharmaceuticals from proprietary biomedical devicesCollaboration with Organic Coating and Polymers Division. Acute and Chronic Toxicity study of Chymosin in rats and rabbits.January 2006 19. September –2006 10. Chronic Toxicity Study of Ayurvedic Bhasma ‘e’ in rats and mice.
Maharashtra. Hyderabad – January 2003. A comparative evaluation of invitro drug release from Atenolol Tablets. Rabprazole Injection –A 14 day Intravenous Toxicity study in mice and rats. M/s. Evaluation Of Anti Inflammatory Potential Of Synthetic Compounds In Rat Paw Edema Model M/s V Life Sciences Technologies Pvt Ltd. M/s Aurobindo Pharma Limited. 41. Sponsored by M/s Lyka Labs Limited. Chennai – December 2002. 36. Hyderabad. Care Polymed Limited. M/s Nichloas Pirmal India Ltd. Acute Oral Toxicity of Citalopram Hydrobromide in rats and mice. Gwalior – September 2004 29. MSN Laboratories. 40. M/S Biological E. Ltd. Subacute Toxicity Study of Tirofiban Hydrochloride in Rats and Mice. Bharat Biotech International Ltd. M/s. Pre-clinical toxicological evaluation of Recombinant Human Epidermal Growth Factor (rh-EGF). January 2004 35. 38. . Hyderabad – September 2002. Pharmacokinetic studies of an arsenic antidote Monoisoamyl dimercapto succinic acid (MiADMSA) in Wistar rats. Hyderabad – February 2003. Limited. Toxicological Evaluation of rh-Hepatitis ‘B’ Vaccine in Rabbits and Mice. Orchid Chemicals & Pharmaceuticals Ltd. 42. Subacute toxicity study (28 days) of “Anticoagulant”. Jalagaon... Hyderabad – July 2004 26. Faridabad – February 2003.. May 2004 34. Sponsored by M/s Biological E. M/s. M/s Lupin Limited – October 2004 30.October 2004 31. 37. M/s. Acute oral toxicity of Ceftiofur Sodium (sterile) in rats and mice. sponsored by M/s APL Research Centre. Report of the Possible Ill-effects of Over-exposure of Population to Exhaust Emission. Ltd. Mumbai. Hyderabad – September 2004 28.25. . M/s. Evaluation Of Anti Inflammatory Potential Of The Compound Ar – 001 In Rat Paw Edema Model. M/s. Gland Pharma Ltd. Ltd. Hyderabad – October 2002. February 2004 32.. Hyderabad – August 2002. M/s. Evaluation Of Anti Inflammatory Activity Of The Compound Lhr –2446ar1 In Rat Paw Edema Model. Sponsored by M/s Mital Musli Farm. Sub acute Toxicity Study Of Rosuvastatin Calcium And Ezetimibe in Mice And Rats.. M/s. Sain Medicaments Pvt. Indian Oil Corporation Limited. Preclinical Toxicity Evaluation of Haemophilus Influenzae Type B Conjugate Vaccine in rats and rabbits. Part A: Bioanalytical method development and validation.. April 2004 33. Sub-acute toxicity study of safed Musli in Wister Rats and Swiss Mice. 39. Defence Research And Development Establishment. Comparative Pharmacokinetic Evaluation of Gentamicin Polymer Adducts in Sprague Dawley Rats.. Pre-clinical Toxicity Evaluation of Drug Eluting Stents in Rabbits.. Hyderabad – February 2003. Biological E. Pune – July 2004 27.
1997. M/s.1996. M/s. . M/s Torrent Pharmaceuticals Ltd. Concord Drugs. Hamdard National Foundation. Defence Research and Development Establishment (DRDE). M/s. 54. M/s Bharat Biotech International Ltd. Gwalior – June 2002. NATCO Pharma. M/s. Hyderabad – 2000 52.. Transgene Vaccines Ltd. Hyderabad . Hyderabad . 56. 1995. Acute toxicity study of Losartan Potassium in Rats. New Delhi – July 2001.1999. M/s Sri Chakra Remedies Ltd. Hyderabad. 1995. Acute and Subacute toxicity study of Streptokinase in Rats and Guinea pigs. Hyderabad. 1995. Limited. 61. M/s.May 2000.1999. Hyderabad. 51. Subacute toxicity study of Jigrine Tablets in rats and mice. 55. New Delhi . Biological E. 60. M/s Memory Polymers. Chronic toxicity study of Hepatitis ‘B’ vaccine in Mice and Guinea pigs. Aurobindo Pharma Ltd. 44. M/s 57. Hamdard.. 49. Report on the Pharmacokinetic Evaluation of DRDE 07. 47. Subacute toxicity study of “Revivin” (a herbal revitalizer) in mice and rats.December 2001. Win Medicare Limited. M/s. 50.2000. Ahmedabad .. 48. Bioadhesive toxicity study of 2-Isoamyl cyano acrylate in Rats and Mice. Aurobindo Pharma Ltd. Hyderabad . M/s Bharat Biotech International Ltd. Hyderabad – July 2002. Subacute toxicity study of Low Molecular Weight Heparin. Subacute toxicity study of Jigrine tablets and capsules in rats and mice. 45. M/s. Acute dermal toxicity and delayed hypersensitivity evaluation of cosmetic creams.2000. in rats and mice. Subacute toxicity study of n-butyl cyanoacrylate . Subacute toxicity study of n-butyl cyanoacrylate .. Gwalior – June 2002 46. 59.a bioadhesive. 58. New Delhi . Subacute toxicity study of Jigrine Capsules in rats and mice. M/s Nector Laboratories. Hyderabad. Hyderabad .1998.. Subacute toxicity study of Recombinant Hepatitis ‘B’ Vaccine in rats and mice. Subacute toxicity study of Indinavir Sulphate in rats and mice.. Natco Pharma Ltd. A 7 Day acute toxicity study of Omeprazole Injection in mice. Hyderabad .a bioadhesive.. Subacute toxicity study of Sildenafil Citrate in rats and mice. Defence Research & Development Establishment. M/s. Bioequivalence of Diclofenac Sodium sustained release tablets in healthy human volunteers. Hamdard National Foundation. New Delhi – September 2001. in rats and mice. 1995.. Hyderabad . 53.43. “Pharmacokinetics of the Antidote (DRDE-07) for sulphur mustard poisoning” M/s.
Married. Indian.0704 Granted on May 4. RAO JANAPALA V (IN).200. YADAV JHILLU S (IN).D Nageswar Sistla Ramakrishna Adari Bhaskar Rao. US 6. . Yadav Jhillu Singh and Raghavan. Diwan Prakash Vamanrao . Publication date: 2005-07-14 Technologies Transferred: * Process know-how for herbal cream formulation for skin and cosmetic applications – M/s Saket Biotechnologies. DIWAN PRAKASH V (IN).V. RAMESH RATNAM (IN). 2002 US 6. 2001 US 6. 2002 Inventors: Ramakrishna Sistla. tiruchenduramine Inventors: VENKATESWARLU YENAMANDRA (IN). Kondapuram Vijaya * Beta-carboline derived guanidine alkaloids. US 6. RAMAKRISHNA SISTLA (IN).495Granted on May 7.73.383. Ramalingam. Hyderabad. PERSONAL: Date of Birth: 30th of August 1965. India .2002. SARATHKUMAR YANDRAPU (IN).673Granted on April 30. LAATSCH HARTMUT (DE) Patent number: US2005222168.379. Y. RAVINDER KODELA (IN). 2004 Inventors: T.570Granted on March 13. Sitaramam Bhamidipalli Subrahmanya Diwan Prakash Vaman Rao and Raghavan Kondapuram Vijaya * 1-(aryloxy)propionoyl-2-arylsulfonyl hydrazines as new hypoglycemic agents. Male. Publication date: 2005-10-06 Patent number: WO2005063748.Patents Granted: * Herbal formulation useful as a therapeutic and cosmetic applications for the treatment of general skin disorders.
This action might not be possible to undo. Are you sure you want to continue?
We've moved you to where you read on your other device.
Get the full title to continue listening from where you left off, or restart the preview.